Study on oxytocin to reduce bleeding during D&E
Part of Women’s health & pregnancy clinical trials.
This trial tests if giving oxytocin before a dilation and evacuation (D&E) procedure helps reduce bleeding. It may help people scheduled for a D&E at 18 weeks or later.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are having a clinic-based D&E at 18 weeks or more of pregnancy
- You speak English or Spanish
- You are not using blood thinners (anticoagulants) in the last 5 days
- You do not have a bleeding disorder or infection in the uterus
- You are not using misoprostol for cervical preparation
- This is not for a pregnancy with multiple babies or fetal loss
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing if a medicine called tranexamic acid (TXA) can help reduce bleeding during a second-trimester abortion or miscarriage procedure. The goal is to make the procedure safer for patients.
This study compares two doses of oxytocin (a medicine given during cesarean section to prevent heavy bleeding) to see which works better for women with high-risk pregnancies. If you are having a planned cesarean and have certain risk factors, this trial may help find the best dose for you.
This trial tests whether giving oxytocin during a dilation and curettage (D&C) procedure for a first-trimester miscarriage helps reduce bleeding and other complications. Oxytocin is a medicine that helps the uterus contract, which may make the procedure safer and more effective.
This study looks at how oxytocin (a medicine often used to help with labor and uterine contractions) moves through the body and what it does during a non-emergency C-section. It may help improve how oxytocin is used in the future for safer, more predictable delivery care.
This trial compares giving oxytocin as a single injection versus a slow drip during C-sections in people at high risk for heavy bleeding after delivery. The goal is to find which method works better to prevent postpartum hemorrhage.
This study compares two medications (tranexamic acid and oxytocin) given directly into the uterus during a planned cesarean section to see which works better at reducing blood loss. It is for women with a single, full-term pregnancy and no major health complications.
Hear when a new Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.